Inventor · disambiguated record
Stephan Märsch
Also filed as: MÄRSCH STEPHAN
7 granted patents·9 pending applications·31 citations·filing 2016–2023
82Inventor score
Top patents by PatentIndex Score
16 records- 0195US11478554B2Antibody drug conjugates (ADCS) having enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0292US11643469B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2022·Granted May 9, 2023·1 cites·15 claims
- 0392US10744205B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodiesBayer Pharma AG·Filed 2016·Granted Aug 18, 2020·9 cites·28 claims
- 0491US11660351B2Antibody drug conjugates (ADCs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted May 30, 2023·5 cites·50 claims
- 0590US11001636B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2017·Granted May 11, 2021·5 cites·15 claims
- 0689US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 0781US2023399411A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2023·Application pending·0 cites
- 0875US2023338559A1Antibody drug conjugates (adcs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 0971US2021230284A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1065US2022362392A1Specific antibody drug conjugates (adcs) having ksp inhibitorsBayer Pharma AG·Filed 2022·Application pending·0 cites
- 1161US11433140B2Specific antibody drug conjugates (ADCs) having KSP inhibitorsBayer Pharma AG·Filed 2017·Granted Sep 6, 2022·0 cites·9 claims
- 1261US2024124572A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1361US2024317847A1INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDINGBAYER AG·Filed 2022·Application pending·0 cites
- 1449US2021275686A1Binder/active agent conjugates directed against cxcr5, having enzymatically cleavable linkers and improved activity profileBAYER AG·Filed 2019·Application pending·0 cites
- 1539US2018318438A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-tweakr-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1636US2018185510A1Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-b7h3-antibodiesBayer Pharma AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →